NUE
55
-2
SWK
37
-2
PNC
61
2
GT
43
-2
SYY
52
2
DVA
52
-5
APD
54
2
AAP
42
-2
MOS
53
4
ADM
57
4
NSC
68
4
EW
43
2
SIG
46
2
EFX
52
2
XRAY
35
-2
ADT
66
-3
ES
49
2
AVGO
40
-2
HON
69
-3
OKE
49
4
NUE
55
-2
SWK
37
-2
PNC
61
2
GT
43
-2
SYY
52
2
DVA
52
-5
APD
54
2
AAP
42
-2
MOS
53
4
ADM
57
4
NSC
68
4
EW
43
2
SIG
46
2
EFX
52
2
XRAY
35
-2
ADT
66
-3
ES
49
2
AVGO
40
-2
HON
69
-3
OKE
49
4
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$49.26
Seasonality Move:
-3.05%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 28.2% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $49.12. The Score for BIB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 28.2% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
45
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • The current trend is moderately bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
49.12
Volume:
5.1K
Beta:
1.80

Technical Analysis

SMA50:
45.74
SMA100:
46.98
SMA200:
52.30
52-Wk Change:
-24.75%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 49.12 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-30 46.33 45.81 46.33 45.46
Jul-1 45.60 46.38 47.59 45.60
Jul-2 46.29 47.91 48.17 46.29
Jul-3 48.00 48.34 48.40 47.95
Jul-7 47.93 46.92 47.93 46.38
Jul-8 47.30 47.72 48.48 47.30
Jul-9 49.68 50.23 50.29 48.98
Jul-10 50.95 51.33 51.51 49.98
Jul-11 50.90 49.72 50.90 49.42
Jul-14 50.25 50.73 50.89 50.25
Jul-15 50.42 48.60 50.42 48.50
Jul-16 50.06 50.42 50.42 50.06
Jul-17 49.84 50.64 50.95 49.84
Jul-18 50.66 49.12 50.66 49.10

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.